A detailed history of Financial Perspectives, Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Perspectives, Inc holds 52 shares of SUPN stock, worth $1,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$1,894
Previous $1.39 Million 16.53%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jan 09, 2024

SELL
$26.72 - $33.19 $34,976 - $43,445
-1,309 Reduced 96.18%
52 $1.6 Million
Q1 2021

Jan 09, 2024

BUY
$24.15 - $31.45 $31,612 - $41,168
1,309 Added 2517.31%
1,361 $52,000
Q1 2020

Jan 09, 2024

SELL
$14.45 - $24.69 $736 - $1,259
-51 Reduced 49.51%
52 $935,000
Q4 2019

Jan 09, 2024

BUY
$19.93 - $29.13 $2,052 - $3,000
103 New
103 $2.44 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.95B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.